Skip to content
Advertisement

FILE - This Oct. 14, 2015 file photo shows the Food and Drug Administration campus in Silver Spring, Md. On Thursday, July 6, 2017, Endo International PLC, the maker of painkiller Opana ER, said it will pull the extended-release opioid drug off the market, a month after being urged to do so by U.S. regulators because of abuse. (AP Photo/Andrew Harnik, File)

FILE - This Oct. 14, 2015 file photo shows the Food and Drug Administration campus in Silver Spring, Md. On Thursday, July 6, 2017, Endo International PLC, the maker of painkiller Opana ER, said it will pull the extended-release opioid drug off the market, a month after being urged to do so by U.S. regulators because of abuse. (AP Photo/Andrew Harnik, File)

Featured Photo Galleries